These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24083601)

  • 1. Melting profiles may affect detection of residual HPV L1 gene DNA fragments in Gardasil®.
    Lee SH
    Curr Med Chem; 2014 Mar; 21(7):932-40. PubMed ID: 24083601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of human papillomavirus (HPV) L1 gene DNA possibly bound to particulate aluminum adjuvant in the HPV vaccine Gardasil.
    Lee SH
    J Inorg Biochem; 2012 Dec; 117():85-92. PubMed ID: 23078778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions.
    Smith JF; Brownlow M; Brown M; Kowalski R; Esser MT; Ruiz W; Barr E; Brown DR; Bryan JT
    Hum Vaccin; 2007; 3(4):109-15. PubMed ID: 17611417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.
    Zhai L; Peabody J; Pang YS; Schiller J; Chackerian B; Tumban E
    Antiviral Res; 2017 Nov; 147():116-123. PubMed ID: 28939477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil HPV vaccine in mice.
    Han JE; Kim HK; Park SA; Lee SJ; Kim HJ; Son GH; Kim YT; Cho YJ; Kim HJ; Lee NG
    Int Immunopharmacol; 2010 Feb; 10(2):169-76. PubMed ID: 19874917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro.
    Wei M; Wang D; Li Z; Song S; Kong X; Mo X; Yang Y; He M; Li Z; Huang B; Lin Z; Pan H; Zheng Q; Yu H; Gu Y; Zhang J; Li S; Xia N
    Emerg Microbes Infect; 2018 Sep; 7(1):160. PubMed ID: 30254257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL; Joura EA
    BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing an HPV vaccine to prevent cervical cancer and genital warts.
    Bryan JT
    Vaccine; 2007 Apr; 25(16):3001-6. PubMed ID: 17289220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial.
    Einstein MH; Takacs P; Chatterjee A; Sperling RS; Chakhtoura N; Blatter MM; Lalezari J; David MP; Lin L; Struyf F; Dubin G;
    Hum Vaccin Immunother; 2014; 10(12):3435-45. PubMed ID: 25483701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice.
    Caulfield MJ; Shi L; Wang S; Wang B; Tobery TW; Mach H; Ahl PL; Cannon JL; Cook JC; Heinrichs JH; Sitrin RD
    Hum Vaccin; 2007; 3(4):139-45. PubMed ID: 17581283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice.
    Han JE; Wui SR; Park SA; Lee NG; Kim KS; Cho YJ; Kim HJ; Kim HJ
    Vaccine; 2012 Jun; 30(28):4127-34. PubMed ID: 22561312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prokaryotic expression of HPV 16 L1 gene and identification of its immune activity].
    Hao DF; Ma ZH; Wang YP; Rexidan ; Zhang FC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):428-31. PubMed ID: 15989783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.
    Inbar R; Weiss R; Tomljenovic L; Arango MT; Deri Y; Shaw CA; Chapman J; Blank M; Shoenfeld Y
    Immunol Res; 2017 Feb; 65(1):136-149. PubMed ID: 27421722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay.
    Brown DR; Garland SM; Ferris DG; Joura E; Steben M; James M; Radley D; Vuocolo S; Garner EI; Haupt RM; Bryan JT
    Hum Vaccin; 2011 Feb; 7(2):230-8. PubMed ID: 21307649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
    Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG
    Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a novel viral DNA vaccine against human papillomavirus: AcHERV-HP16L1.
    Lee HJ; Park N; Cho HJ; Yoon JK; Van ND; Oh YK; Kim YB
    Vaccine; 2010 Feb; 28(6):1613-9. PubMed ID: 19961961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.
    Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B
    Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras.
    Pineo CB; Hitzeroth II; Rybicki EP
    Plant Biotechnol J; 2013 Oct; 11(8):964-75. PubMed ID: 23924054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection.
    Zurek Munk-Madsen M; Toft L; Kube T; Richter R; Ostergaard L; Søgaard OS; Tolstrup M; Kaufmann AM
    Hum Vaccin Immunother; 2018 Apr; 14(4):909-916. PubMed ID: 29172992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.